Hip Replacement for Bone Metastasis & Pathological Fractures 

This section details the adaptive arthroplasty protocols for metastatic bone disease, where standard joint replacement techniques are modified to address massive bone loss and irradiated tissue beds. Developed through the reconstructive practice of Dr. Saminathan Suresh Nathan, these protocols utilize the Harrington and Paprosky classifications to stratify surgical risk and determine the necessity of specialized augments or cryosurgical adjuncts in cancer-inflicted patients. 

Reconstructive Strategy

While primary neoplasms often mandate megaprosthetic limb salvage, metastatic involvement of the proximal femur and acetabulum requires the strategic adaptation of standard arthroplasty techniques. We prioritize these methods over costly tumor prostheses whenever host bone preservation is viable.

In patients with disabling arthritis or metastatic disease, the surgical approach is governed by specific physiological and mechanical constraints:

• Thromboembolic Profile: We observe an $18\%$ baseline risk of Deep Vein Thrombosis (DVT) in metastatic cohorts, which we reduce to $4\%$ ($p=0.006$) through aggressive prophylactic anticoagulation and, where indicated, IVC filtration (Nathan et al., 2006).

• Structural Classification: Risk stratification is achieved by integrating the Harrington classification (oncology) with the Paprosky classification (revision arthroplasty). This determines the necessity for specialized augments, reinforced cement constructs, or modular implants.

• Survival-Based Strategy: Reconstructive options are selected via survival stratification. Patients with advanced lung cancer in extremis may require expedient stabilization, whereas renal cell or breast carcinoma patients with longer prognoses receive definitive hip replacement (Nathan et al., 2005).

• Cryosurgical Adjunct: We utilize Argon gas-based probe technology (Cryohit) as an adjunct for local tumor control. This is particularly critical in irradiated fields where preserving the biological integrity of the remaining host bone is essential for hardware fixation.

Clinical Results and Outcomes

Late presentation following chemotherapy and radiotherapy significantly complicates the surgical environment. We manage these cases with a focus on the following parameters:

• Complication Profile: High rates of implant loosening, superficial infection, and dynamic hip instability due to extreme disuse atrophy are documented in end-stage cases.

• Functional Gains: Despite technical hurdles, we achieve a minimum one-grade improvement in the ECOG functional score across the cohort.

• Ambulation Recovery: Post-operative ambulation is restored in $100\%$ of premorbidly ambulant patients and $70\%$ of those presenting with pathological acetabular protrusion.

• Local Control: Cryosurgery facilitates host bone preservation, allowing for functional reconstructions and providing superior local disease control compared to standard palliative radiation protocols.

Bottom line

Arthroplasty in metastatic disease must be offered early to maintain mechanical integrity and prevent catastrophic bone loss. End-stage reconstructions yield unpredictable outcomes; therefore, early surgical intervention, augmented by cryosurgical adjuncts, is the preferred protocol for managing structural compromise in the metastatic hip.